Related Experiment Video
Updated: Feb 15, 2026

RNAi Screening to Identify Postembryonic Phenotypes in C. elegans
Published on: February 13, 2012
Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic
Lourdes Ortiz-Fernández1, Francisco David Carmona2, Raquel López-Mejías3
1Instituto de Parasitologia y Biomedicina Lopez-Neyra, Granada, Spain.
Insights
This study identified KDM4C as a new shared risk gene for systemic vasculitis, highlighting the role of epigenetics in these rare blood vessel diseases. Genetic analysis revealed a common susceptibility locus, advancing our understanding of vasculitis predisposition.
Area of Science:
- Genetics
- Immunology
- Epigenetics
Background:
- Systemic vasculitides are rare, complex blood vessel diseases with unknown causes.
- Understanding the genetic factors contributing to vasculitis is crucial for developing effective treatments.
Purpose of the Study:
- To identify shared genetic susceptibility loci across different types of systemic vasculitis.
- To investigate the genetic component underlying predisposition to vasculitis.
Main Methods:
- A cross-phenotype meta-analysis of Immunochip genotyping data from 2465 vasculitis patients and 4632 controls.
- Analysis of genetic data from giant cell arteritis, Takayasu's arteritis, antineutrophil cytoplasmic antibody-associated vasculitis, and IgA vasculitis.
- Interrogation of functional consequences of associated variants using public annotation data.
Main Results:
- The strongest association signal was an intergenic polymorphism between HLA-DQB1 and HLA-DQA2 (rs6932517).
- The KDM4C gene was identified as a common risk locus for vasculitides (rs16925200).
- KDM4C encodes a histone demethylase involved in epigenetic gene regulation.
Conclusions:
- KDM4C is identified as a novel shared risk gene for systemic vasculitides.
- This finding supports the significant role of epigenetic mechanisms in the development of immune-mediated diseases.
- The study provides insights into the genetic underpinnings of vasculitis.
Objetive:
Systemic vasculitides represent a heterogeneous group of rare complex diseases of the blood vessels with a poorly understood aetiology. To investigate the shared genetic component underlying their predisposition, we performed the first cross-phenotype meta-analysis of genetic data from different clinically distinct patterns of vasculitis.
Methods:
Immunochip genotyping data from 2465 patients diagnosed with giant cell arteritis, Takayasu's arteritis, antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis as well as 4632 unaffected controls were analysed to identify common susceptibility loci for vasculitis development. The possible functional consequences of the associated variants were interrogated using publicly available annotation data.
Results:
The strongest association signal corresponded with an intergenic polymorphism located between HLA-DQB1 and HLA-DQA2 (rs6932517, P=4.16E-14, OR=0.74). This single nucleotide polymorphism is in moderate linkage disequilibrium with the disease-specific human leucocyte antigen (HLA) class II associations of each type of vasculitis and could mark them. Outside the HLA region, we identified the KDM4C gene as a common risk locus for vasculitides (highest peak rs16925200, P=6.23E-07, OR=1.75). This gene encodes a histone demethylase involved in the epigenetic control of gene expression.
Conclusions:
Through a combined analysis of Immunochip data, we have identified KDM4C as a new risk gene shared between systemic vasculitides, consistent with the increasing evidences of the crucial role that the epigenetic mechanisms have in the development of complex immune-mediated conditions.
Related Concept Videos
Monohybrid Crosses
Dihybrid Crosses
Cross-Sectional Research
Locus of Control
Crossing Over
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process...
Analysis of Population Pharmacokinetic Data

